Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	248.28	326.33	317.5	474.88	651.55	1,029
Short-Term Investments	725.61	509.69	591.22	658.47	696.8	366.3
Trading Asset Securities	-	-	-	18.66	17.77	19.65
Cash & Short-Term Investments	973.88	836.03	908.72	1,152	1,366	1,415
Cash Growth	0.52%	-8.00%	-21.12%	-15.67%	-3.43%	-11.82%
Accounts Receivable	131.08	130.85	175.16	138.92	130.52	149.05
Other Receivables	4.98	4.52	2.61	2.8	1.84	2.06
Receivables	136.05	135.36	177.77	141.71	132.36	151.11
Inventory	165.09	168.54	161.79	188.76	115.2	115.18
Prepaid Expenses	14.3	24.31	12.21	16.43	3.84	7.84
Other Current Assets	29.83	2.89	8.26	125.78	2.04	2.13
Total Current Assets	1,319	1,167	1,269	1,625	1,620	1,691
Property, Plant & Equipment	26.17	30.62	29.51	7.65	14.54	22.51
Long-Term Investments	265.75	360.37	418.6	119.7	134.74	93.33
Other Intangible Assets	0.31	0.41	0.6	0.79	0.05	0.25
Long-Term Accounts Receivable	9.83	12.29	17.1	-	1.99	6.68
Long-Term Deferred Tax Assets	7.84	7.45	10.41	7.77	6.71	10.07
Other Long-Term Assets	15.35	12.46	4.81	4.83	5.63	7.33
Total Assets	1,644	1,591	1,750	1,765	1,783	1,831

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	61.22	29.8	25.9	62.69	46.71	89.95
Accrued Expenses	66.76	76.71	81	96.88	80.1	95.23
Current Portion of Leases	11.12	10.94	9.81	5.05	10.08	9.83
Current Income Taxes Payable	36.92	30.26	56.41	80.35	40.51	40.15
Current Unearned Revenue	20.8	21.6	11.52	8.26	8.05	13.59
Other Current Liabilities	147.62	35.26	68.57	35.65	33.75	30.42
Total Current Liabilities	344.44	204.56	253.2	288.88	219.18	279.16
Long-Term Leases	24.43	30.04	36.96	-	5.6	15.68
Long-Term Deferred Tax Liabilities	0.37	-	3.3	0.98	28.18	-
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.26	1.26
Total Liabilities	370.5	235.86	294.71	291.12	254.22	296.1

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	151.7	151.7	241.8	331.89	421.99	512.08
Retained Earnings	671.72	752.67	762.78	691.96	548.78	479.09
Comprehensive Income & Other	-	-	-	-	107.77	93.31
Shareholders' Equity	1,274	1,355	1,455	1,474	1,529	1,535
Total Liabilities & Equity	1,644	1,591	1,750	1,765	1,783	1,831

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	35.55	40.98	46.77	5.05	15.68	25.5
Net Cash (Debt)	938.33	795.05	861.95	1,147	1,350	1,389
Net Cash Growth	1.23%	-7.76%	-24.85%	-15.07%	-2.78%	-11.54%
Net Cash Per Share	20.77	17.60	19.08	25.44	29.95	30.80
Filing Date Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Working Capital	974.71	962.56	1,016	1,336	1,400	1,412
Book Value Per Share	28.28	30.08	32.30	32.73	33.94	34.07
Tangible Book Value	1,274	1,354	1,454	1,474	1,529	1,535
Tangible Book Value Per Share	28.27	30.07	32.29	32.71	33.94	34.07

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error